NICHOLAS CHUCK: Open Payments
NPI 1891340410 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 31 payments from 10 companies in 2025. Trend: 2023 $1,171 · 2024 $1,045 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $156 |
| ABBVIE INC. | 5 | $101 |
| SHIELD THERAPEUTICS INC | 2 | $60 |
| Lilly USA, LLC | 3 | $55 |
| Novo Nordisk Inc | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| PFIZER INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: OTEZLA, QULIPTA, ACCRUFER, TRELEGY ELLIPTA, UBRELVY, Ozempic, EVENITY, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
